Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them
Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.
Gen Li, PhD, MBA
Advertisement
Articles by Gen Li, PhD, MBA
A discussion of the cost and time put into clinical trials.
Advertisement
Latest Updated Articles
Clinical Trials Don't Have to Cost Too Much or Take Too LongPublished: May 8th 2018 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
